Gilead

Some nonhospitalized patients seeking treatment for COVID-19 can now use the antiviral remdesivir after U.S. drug regulators on Jan. 21 expanded approval of the drug. The Food and Drug Administration ...

The U.S. Food and Drug Administration on Thursday approved Gilead Sciences's antiviral drug remdesivir for the treatment of adults ...

BRUSSELS—The European Union's executive said on Wednesday it had agreed to buy a limited supply of the COVID-19 ...

The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will ...

The U.S. National Institutes of Health (NIH) on Friday said that data from its trial of Gilead Sciences ...

With the FDA approving Gilead’s Remdesivir as an emergency use treatment for the most acute cases of COVID-19, many people ...

Gilead Sciences has increased the number of patients involved in two trials for its experimental COVID-19 treatment remdesivir. ...

The new CCP virus made Dr. Jag Singh a patient at his own hospital. His alarm grew as ...

After an 18 month investigation into the high cost of Gilead's hepatitis C drug Sovaldi—initially listed at $84,000 ...

WASHINGTON—The makers of a breakthrough hepatitis drug put profits before patients in pricing the $1,000 pill that's become ...